Grandfield & Dodd’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-7,016
Closed -$1.29M 213
2021
Q2
$1.29M Sell
7,016
-356
-5% -$65.5K 0.09% 89
2021
Q1
$1.13M Sell
7,372
-95
-1% -$14.6K 0.08% 91
2020
Q4
$1.17M Buy
7,467
+300
+4% +$47K 0.09% 89
2020
Q3
$820K Buy
7,167
+145
+2% +$16.6K 0.07% 101
2020
Q2
$790K Buy
7,022
+670
+11% +$75.4K 0.08% 104
2020
Q1
$570K Buy
6,352
+502
+9% +$45K 0.07% 109
2019
Q4
$633K Buy
5,850
+705
+14% +$76.3K 0.06% 118
2019
Q3
$504K Buy
5,145
+685
+15% +$67.1K 0.05% 130
2019
Q2
$584K Buy
4,460
+432
+11% +$56.6K 0.06% 121
2019
Q1
$545K Buy
4,028
+72
+2% +$9.74K 0.06% 125
2018
Q4
$385K Buy
3,956
+76
+2% +$7.4K 0.05% 132
2018
Q3
$539K Buy
3,880
+35
+0.9% +$4.86K 0.06% 125
2018
Q2
$477K Buy
3,845
+30
+0.8% +$3.72K 0.05% 129
2018
Q1
$425K Sell
3,815
-30
-0.8% -$3.34K 0.05% 138
2017
Q4
$460K Buy
3,845
+60
+2% +$7.18K 0.05% 141
2017
Q3
$531K Buy
3,785
+425
+13% +$59.6K 0.06% 127
2017
Q2
$409K Buy
3,360
+90
+3% +$11K 0.05% 144
2017
Q1
$396K Buy
3,270
+47
+1% +$5.69K 0.05% 141
2016
Q4
$394K Buy
3,223
+385
+14% +$47.1K 0.05% 140
2016
Q3
$348K Buy
2,838
+225
+9% +$27.6K 0.05% 146
2016
Q2
$305K Buy
2,613
+114
+5% +$13.3K 0.04% 149
2016
Q1
$348K Buy
2,499
+940
+60% +$131K 0.05% 133
2015
Q4
$297K Buy
+1,559
New +$297K 0.05% 145
2015
Q3
Sell
-1,240
Closed -$224K 179
2015
Q2
$224K Hold
1,240
0.03% 161
2015
Q1
$215K Hold
1,240
0.03% 157
2014
Q4
$229K Sell
1,240
-9
-0.7% -$1.66K 0.04% 153
2014
Q3
$207K Buy
+1,249
New +$207K 0.03% 157